|
Apr 9
|
Dundee Corporation Renews Normal Course Issuer Bid on Class A Subordinate Voting Shares
|
|
Oct 7
|
Dundee Corporation Completes Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 Million
|
|
Dec 28
|
Dundee Corporation Announces Results of Substantial Issuer Bid for Its Series 3 Preferred Shares
|